David C. Atkins

Lynn University — United States

Psychology · Social Sciences

82h-index33.0kcitations407works5.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Attachment and Relationship Dynamics(49), Digital Mental Health Interventions(47), Psychotherapy Techniques and Applications(45), Mental Health Research Topics(41), Substance Abuse Treatment and Outcomes(40)

Publications407 total

Artificial Intelligence to Support Human-Provided Mental Health Treatment
Annual Review of Clinical Psychology·2026
Veterans Affairs Research Under Threat
JAMA Internal Medicine·2025· 3 cited
Buprenorphine, Pain, and Opioid Use in Patients Taking High-Dose Long-Term Opioids
JAMA Internal Medicine·2025· 8 citedOpen Access
Association of machine-learning-rated supportive counseling skills with psychotherapy outcome.
Journal of Consulting and Clinical Psychology·2025· 1 citedOpen Access
Care Models to Improve Pain and Reduce Opioids Among Patients Prescribed Long-Term Opioid Therapy
JAMA Internal Medicine·2024· 14 citedOpen Access
Machine Learning–Based Evaluation of Suicide Risk Assessment in Crisis Counseling Calls
Psychiatric Services·2024· 2 citedOpen Access
Automating the assessment of multicultural orientation through machine learning and natural language processing.
Psychotherapy·2024· 5 citedOpen Access
Outcomes in Mental Health Counseling From Conversational Content With Transformer-Based Machine Learning
JAMA Network Open·2024· 14 citedOpen Access
Improving the quality of counseling and clinical supervision in opioid treatment programs: how can technology help?
Addiction Science & Clinical Practice·2024· 4 citedOpen Access
Machine-Learning-Based Prediction of Client Distress From Session Recordings
Clinical Psychological Science·2023· 13 citedOpen Access
Supplementary Data from Identification of Molecular Predictors of Response in a Study of Tipifarnib Treatment in Relapsed and Refractory Acute Myelogenous Leukemia
2023Open Access
Supplementary Data, Figure S1 and Table S1 from Novel Genes Associated with Malignant Melanoma but not Benign Melanocytic Lesions
2023Open Access
Data from Novel Genes Associated with Malignant Melanoma but not Benign Melanocytic Lesions
2023Open Access
Supplementary Figures S1-S3 from Identification of Molecular Predictors of Response in a Study of Tipifarnib Treatment in Relapsed and Refractory Acute Myelogenous Leukemia
2023Open Access
Data from Novel Genes Associated with Malignant Melanoma but not Benign Melanocytic Lesions
2023Open Access
Supplementary Data, Figure S1 and Table S1 from Novel Genes Associated with Malignant Melanoma but not Benign Melanocytic Lesions
2023Open Access
Data from Identification of Molecular Predictors of Response in a Study of Tipifarnib Treatment in Relapsed and Refractory Acute Myelogenous Leukemia
2023Open Access
Supplementary Figures S1-S3 from Identification of Molecular Predictors of Response in a Study of Tipifarnib Treatment in Relapsed and Refractory Acute Myelogenous Leukemia
2023Open Access
Supplementary Data from Identification of Molecular Predictors of Response in a Study of Tipifarnib Treatment in Relapsed and Refractory Acute Myelogenous Leukemia
2023Open Access
Data from Identification of Molecular Predictors of Response in a Study of Tipifarnib Treatment in Relapsed and Refractory Acute Myelogenous Leukemia
2023Open Access
page 1 of 21Next →

Frequent Co-authors

Andrew Christensen(5), Zac E. Imel(5), Gordon Guyatt(4), Andrew D Oxman(4), Holger J. Schünemann(4), Gunn Elisabeth Vist(4), Robert Gallop(4), Donald H. Baucom(4), Clayton Neighbors(4), Martin Eccles(3), Signe Flottorp(3), Suzanne Hill(3), Roman Jaeschke(3), Alessandro Liberati(3), Bob Phillips(3), Tessa Tan-Torres Edejer(3), John W Williams(3), Joseph B. McGlinchey(3), Neil S. Jacobson(3), Scott A. Baldwin(3)